Bullough DA[au] - Search Results

Year	Number of Results
1985	1
1986	4
1987	1
1988	2
1989	2
1991	4
1993	1
1994	2
1995	2
1996	1
1997	2
2003	1
2004	1
2005	1
2006	1
2008	1
2024	0

1

Liver-targeted drug delivery using HepDirect prodrugs.

Erion MD, van Poelje PD, Mackenna DA, Colby TJ, Montag AC, Fujitaki JM, Linemeyer DL, Bullough DA. Erion MD, et al. Among authors: bullough da. J Pharmacol Exp Ther. 2005 Feb;312(2):554-60. doi: 10.1124/jpet.104.075903. Epub 2004 Aug 31. J Pharmacol Exp Ther. 2005. PMID: 15340017

2

HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.

Erion MD, Bullough DA, Lin CC, Hong Z. Erion MD, et al. Among authors: bullough da. Curr Opin Investig Drugs. 2006 Feb;7(2):109-17. Curr Opin Investig Drugs. 2006. PMID: 16499280 Review.

3

Inactivation of the bovine heart mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyl[3H]inosine is accompanied by modification of tyrosine 345 in a single beta subunit.

Bullough DA, Allison WS. Bullough DA, et al. J Biol Chem. 1986 Oct 25;261(30):14171-7. J Biol Chem. 1986. PMID: 2876984 Free article.

4

Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects.

Villarreal F, Zimmermann S, Makhsudova L, Montag AC, Erion MD, Bullough DA, Ito BR. Villarreal F, et al. Among authors: bullough da. Mol Cell Biochem. 2003 Sep;251(1-2):17-26. Mol Cell Biochem. 2003. PMID: 14575299 Review.

5

Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.

Fujitaki JM, Cable EE, Ito BR, Zhang BH, Hou J, Yang C, Bullough DA, Ferrero JL, van Poelje PD, Linemeyer DL, Erion MD. Fujitaki JM, et al. Among authors: bullough da. Drug Metab Dispos. 2008 Nov;36(11):2393-403. doi: 10.1124/dmd.108.021642. Epub 2008 Aug 14. Drug Metab Dispos. 2008. PMID: 18703645

6

Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine.

Bullough DA, Magill MJ, Mullane KM, Firestein GS. Bullough DA, et al. Cardiovasc Res. 1996 Aug;32(2):328-34. doi: 10.1016/0008-6363(96)00052-1. Cardiovasc Res. 1996. PMID: 8796120

7

The varied responses of different F1-ATPases to chlorpromazine.

Bullough DA, Kwan M, Laikind PK, Yoshida M, Allison WS. Bullough DA, et al. Arch Biochem Biophys. 1985 Feb 1;236(2):567-75. doi: 10.1016/0003-9861(85)90660-5. Arch Biochem Biophys. 1985. PMID: 2857548

8

Three copies of the beta subunit must be modified to achieve complete inactivation of the bovine mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyladenosine.

Bullough DA, Allison WS. Bullough DA, et al. J Biol Chem. 1986 May 5;261(13):5722-30. J Biol Chem. 1986. PMID: 2871017 Free article.

9

Inhibition of the bovine-heart mitochondrial F1-ATPase by cationic dyes and amphipathic peptides.

Bullough DA, Ceccarelli EA, Roise D, Allison WS. Bullough DA, et al. Biochim Biophys Acta. 1989 Aug 3;975(3):377-83. doi: 10.1016/s0005-2728(89)80346-9. Biochim Biophys Acta. 1989. PMID: 2527062

10

Localization of sites modified during inactivation of the bovine heart mitochondrial F1-ATPase by quinacrine mustard using [3H]aniline as a probe.

Bullough DA, Ceccarelli EA, Verburg JG, Allison WS. Bullough DA, et al. J Biol Chem. 1989 Jun 5;264(16):9155-63. J Biol Chem. 1989. PMID: 2524484 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year